• Reimbursement Decisions for Pharmaceuticals in Sweden- the Impact of Cost-Effectiveness and Disease Severity

    Nov 1, 2014, 00:00

  • Should Changes in Drug Price Over Time be Considered in Cost-Effectiveness Analyses?

    Nov 1, 2014, 00:00

  • Health Behavior And Medication Adherence

    Nov 1, 2014, 00:00

  • Estimating the Voi of Pivotal Studies Towards Predictive Biomarkers of High Dose Alkylating Chemotherapy in Triple Negative Breast Cancer

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of Wider Adoption Of Biphasic Insulin Aspart (Biasp) In The Treatment Of Type 2 Diabetes Mellitus (T2dm)- A Perspective Of Patients Treated By Public Providers In Singapore

    Nov 1, 2014, 00:00

  • Preference for Rituximab Subcutaneous (Sc) and Intravenous (Iv) Among Patients With Cd20+ Non-Hodgkin's Lymphoma (Nhl) Completing the Rasq Measure In Randomized Phase Iii Studies Prefmab and Mabcute

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Laser Doppler Imaging in Burn Care in The Netherlands; A Randomised Controlled Trial

    Nov 1, 2014, 00:00

  • Xpert Mtb/Rif Assay for Rapid Diagnosis in Patients with Suspected Tuberculosis in Hong Kong - a Cost-Effectiveness Analysis

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Ofatumumab Plus Chlorambucil in First Line Chronic Lymphocytic Leukemia in Canada

    Nov 1, 2014, 00:00

  • Comparative Efficacy And Tolerability Of Solifenacin 5mg Versus Oral Antimuscarinic Agents In Overactive Bladder (Oab)- A Systematic Literature Review (Slr) And Mixed Treatment Comparison (Mtc)

    Nov 1, 2014, 00:00

  • A Systematic Literature Review to Identify Trials in First-Line Ras Wild-Type (WT) Metastatic Colorectal Cancer (MCRC) Patients

    Nov 1, 2014, 00:00

  • Loyalty To A Pharmacy Is Associated With A Better Quality Of Antidiabetes Drug Use

    Nov 1, 2014, 00:00

  • Indirect Comparison of Exacerbation Frequency Between Aclidinium and Tiotropium in Patients With Chronic Obstructive Pulmonary Disease

    Nov 1, 2014, 00:00

  • Cost Effectiveness Analysis of A Vaccine To Prevent Herpes Zoster and Postherpetic Neuralgia in Italy

    Nov 1, 2014, 00:00

  • Efficacy and Safety of Paliperidone Palmitate in the Treatment of Schizophrenia- A Meta-Analysis

    Nov 1, 2014, 00:00

  • Direct and Indirect Costs Associated With Increasing Body Mass Index (Bmi) In the Eu5

    Nov 1, 2014, 00:00

  • Adaptive Video Games can Assess and Enhance Cognitive Health

    Nov 1, 2014, 00:00

  • Evaluation of Adverse Drug Reaction (ADR) Monitoring and Reporting System in China

    Nov 1, 2014, 00:00

  • An Analysis of Us Medicare Beneficiaries- Burden of Direct Medical Costs in Patients With Idiopathic Pulmonary Fibrosis

    Nov 1, 2014, 00:00

  • Patients' Priorities in the Treatment of Neuroendocrine Tumors- An Analytic Hierarchy Process

    Nov 1, 2014, 00:00

  • Cost Analysis of Severe Hypoglycemia in Treated Type 2 Diabetic Patients According to Anti-Hyperglycemic Agent Therapy

    Nov 1, 2014, 00:00

  • Creating Patient Profile in Individual Simulations- A Comparison of Approaches

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of Apixaban Versus Other Noacs For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation Patients

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of Sofosbuvir For The Treatment Of Hepatitis C In The Veneto Region, Italy

    Nov 1, 2014, 00:00

  • Assessment Of Knowledge Regarding Diabetes- A Comparative Analysis Of Diabetes Patients And Healthy Population Of Quetta City, Pakistan

    Nov 1, 2014, 00:00

  • A Cost-Utility Analysis of Calcium Channel Blockers (Ccbs) Compared with Angiotensin II Receptor Blockers (Arbs) In Preventing Stroke And Myocardial Infarction Among Hypertension Patients In The Taiwan

    Nov 1, 2014, 00:00

  • Survival Status in (Pharmaco) Epidemiological Studies can be Successfully Investigated Using Administrative Residential Registries

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Percent Free Psa for Prostate Cancer Detection in Chinese Men with a Total Psa of 4.0-10.0 Ng/Ml

    Nov 1, 2014, 00:00

  • Quality of Life and the Predictors of Thai Depressive Disorders Patients

    Nov 1, 2014, 00:00

  • Treatment Effect Heterogeneity in Clinical Trials- An Evaluation of 13 Large Clinical Trials Using Individual Patient Data

    Nov 1, 2014, 00:00

  • Sources of Information and Pharmacists' Knowledge Regarding Rare Diseases and Orphan Drugs- Cross-Sectional Study In Serbia

    Nov 1, 2014, 00:00

  • Understanding the Payer Dilemma with Biosimilar Mabs- Striking the Right Balance Between Budget Needs and Patient Outcomes

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Protease Inhibitor Monotherapy Verse Ongoing Triple-Therapy in the Long-Term Management of HIV Patients

    Nov 1, 2014, 00:00

  • The Econimic Cost of Rheumatoid Arthritis in Taiwan

    Nov 1, 2014, 00:00

  • Assessing the Translatability of the Term “Frustrated”

    Nov 1, 2014, 00:00

  • Costs Related to Pneumonia, Meningitis and Sepsis in Patients 50 Years and Older from the Private Health System Perspective in Brazil

    Nov 1, 2014, 00:00

  • Physicians Estimation Regarding The Impact Of Recession on Patient Adherence To Treatment In Diabetes Type 2 In Greece

    Nov 1, 2014, 00:00

  • Economic Impact Linked To the Reduction of Exacerbations When A Treatment Regime With Inhaled Antibiotics Is Switched To Aztreonam Lysine In Patients With Cystic Fibrosis and Chronic Pulmonary Infection Caused By Pseudomonas Aeruginosa

    Nov 1, 2014, 00:00

  • Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors- Systematic Review and Meta-Analysis

    Nov 1, 2014, 00:00

  • Pain Therapy for Osteoarthritis in Germany- Analysis of Sickness Fund Claims Data

    Nov 1, 2014, 00:00

  • Nursing Diagnosis and Some Physiological Signs and Their Changes During the Arterial Hypertension

    Nov 1, 2014, 00:00

  • Real-World Data on the Epidemiology and Treatment of HR +, HER2-Advanced Breast Cancer in Postmenopausal Patients in Different Regions of Russia for Forming Markov Models of Managment of Patients

    Nov 1, 2014, 00:00

  • The Valuation of EQ-5D-5L Health States in Korea

    Nov 1, 2014, 00:00

  • Does Not Reaching an Agreement on the Final Nice Scope Have Any Impact on The Final Apraisal Outcome?

    Nov 1, 2014, 00:00

  • A Database Analysis Of Patients Eligible For Second-Line Lipid-Lowering Treatment For Hypercholesterolaemia In England

    Nov 1, 2014, 00:00

  • Encepp-HTA Working Group Survey on Capacity To Conduct Research in Support Of Health Technology Assessment

    Nov 1, 2014, 00:00

  • Health Insurance Cost of Anxiety in Hungary- A Cost of Illness Study

    Nov 1, 2014, 00:00

  • Implications for Time Savings Using New Intraoperative Measuring Technology

    Nov 1, 2014, 00:00

  • Selection of Topics For Nice Technology Appraisal 2005-2011- What Matters Most?

    Nov 1, 2014, 00:00

  • Non-Proliferative Diabetic Retinopathy- is It Cost-Effective to Treat Early?

    Nov 1, 2014, 00:00

  • Costs of Absenteeism In Ankylosing Spondylitis Based On Real-Life Data From Poland's Social Insurance Institution Database In 2012

    Nov 1, 2014, 00:00

  • Systematic Review of the Economics of Multiple Sclerosis in Latin America

    Nov 1, 2014, 00:00

  • Patterns of Asthma Treatment Utilization in Newly Diagnosed Elderly Patients are Inconsistent With Asthma Management Guidelines

    Nov 1, 2014, 00:00

  • A Gender Medicine Post-Hoc Analysis- Background and Methods of the Metagem Project

    Nov 1, 2014, 00:00

  • A Comparison of Asian and Global Pharmaceutical Prices Using an EKS Method

    Nov 1, 2014, 00:00

  • Impact of the Early Benefit Assessment on A Pharmaceutical's Real Consumption in Germany

    Nov 1, 2014, 00:00

  • Economic Evaluation of Bevacizumab Versus Ranibizumab in Neovascular Age-Related Macular Degeneration in China

    Nov 1, 2014, 00:00

  • Cost Minimization Analysis of Activated Prothrombin Complex Concentrate (Apcc) Compared To Recombinant Factor Viia (Rfviia) for Hemophilia Patients With Inhibitors

    Nov 1, 2014, 00:00

  • Can Gastric Cancer Patients be Successfully Recruited for Clinical Phase III/IV and Health Outcome Studies Using Managed Physician Panels?

    Nov 1, 2014, 00:00

  • Chronic Care Management

    Nov 1, 2014, 00:00

  • Preventing the Progression to Type 2 Diabetes Mellitus in Adults at High Risk- A Systematic Review And Network Meta-Analysis of Lifestyle, Pharmacological and Surgical Interventions

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis of Certolizumab Pegol Plus Methotrexate for the Treatment of Moderate-To-Severe Active Rheumatoid Arthritis In Greece

    Nov 1, 2014, 00:00

  • Does Giving Carers a Break Improve their Wellbeing? Results from an Evaluation using the EQ-5D-5L

    Nov 1, 2014, 00:00

  • Health Care Utilization and Costs of Medicaid Program Services for Patients Diagnosed with Multiple Sclerosis

    Nov 1, 2014, 00:00

  • Quality Of Life in Teenagers and Young Adolescent Patients With Diabetes Mellitus Type I With Insulin Pens Or Insulin Pumps In The Czech Republic

    Nov 1, 2014, 00:00

  • Identification of Dry Powder Inhaler Attributes, and their Relative Importance to Asthma and Chronic Obstructive Pulmonary Disease Patients, to Inform a Discrete Choice Experiment

    Nov 1, 2014, 00:00

  • A Dutch Administrative Database in Support of Economic Evaluations- A Feasibility Study

    Nov 1, 2014, 00:00

  • Self Reported Health Care Resource Use and Indirect Economic Burden of Opioid Induced Constipation (Oic)

    Nov 1, 2014, 00:00

  • The Oncology Pain Treatment Clinical Studies Quality Assessment

    Nov 1, 2014, 00:00

  • Cost–Effectiveness of Clopidogrel-Aspirin Versus Aspirin Alone for Acute Tia and Minor Stroke

    Nov 1, 2014, 00:00

  • Potential Efficency and Cost Savings To the English Nhs By A Laparoscopic Aproach To Total Abdominal Hysterectomy

    Nov 1, 2014, 00:00

  • The Effectiveness Of Carotid Artery Stenting Compared With Endarterectomy In Symptomatic Patients With Carotid Stenosis In Korean Multi-Center Setting

    Nov 1, 2014, 00:00

  • Histoculture Drug Response Assay in Colorectal Cancer

    Nov 1, 2014, 00:00

  • The Reimbursement of Expensive Drugs In Hospitals in Western European Countries

    Nov 1, 2014, 00:00

  • Cost of Non Small Cell Lung Cancer by Vietnamese and European Treatment Standards in Vietnam

    Nov 1, 2014, 00:00

  • Results of A Decubitus Prevention and Wound Care Project

    Nov 1, 2014, 00:00

  • Survival After Locoregional Recurrence or Second Primary Breast Cancer- Impact of the Disease-Free Interval

    Nov 1, 2014, 00:00

  • Assessment of Health States and Erectile Dysfunction-Associated Quality of Life Among Adult Males and Females With Male Partners in Germany, the United Kingdom and the United States

    Nov 1, 2014, 00:00

  • The Pension Costs of Musculoskeletal Diseases. Estimation of the Economic Burden Borne by the Italian Social Security System

    Nov 1, 2014, 00:00

  • Smoking Cessation Treatment Patterns and Characteristics of Patients with Copd Who are Attempting to Quit in Urban China

    Nov 1, 2014, 00:00

  • Impact of Morbidity in Populations of North London Clinical Commissioning Groups on Patient Admission Rates and Gp Referrals

    Nov 1, 2014, 00:00

  • An Analysis of the Drivers of Pricing Premiums Granted to Innovative Products in Japan

    Nov 1, 2014, 00:00

  • Mixed Treatment Comparisons to Compare Simeprevir with Boceprevir and Telaprevir in Combination with Peg-Interferon Alpha and Ribavirin (Pr) in Patients Infected with Genotype 1 Hepatitis C Virus (Hcv)

    Nov 1, 2014, 00:00

  • A Cost Effectiveness Analysis of Everolimus Plus Exemestane Compared to Chemotherapy Agents for the Treatment of ER+ HER2- Metastastic Breast Cancer in the United Kingdom

    Nov 1, 2014, 00:00

  • In Vitro Drug Release and Ex Vivo Permeation Study of Prepared Mouth Dissolving Tablets of Fluconazole Through Porcine Buccal Mucosa

    Nov 1, 2014, 00:00

  • Health Economic Model On the Costs and Effects of Rotavirus Vaccination in Romania

    Nov 1, 2014, 00:00

  • Awareness and Interest in the United States Health Insurance Marketplace

    Nov 1, 2014, 00:00

  • Impact of Patient Programs On Adherence In Inflammation and Immunology- A Global Systematic Review and Meta-Analysis of Published Evidence

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Celecoxib and Non Selective Non Steroidal Anti-Inflammatory Drug (Nsaid) Therapy for the Treatment of Osteoarthritis in Spain- A Decision-Tree Model

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of Para-Aortic Lymphadenectomy Before Chemoradiotherapy in Locally Advanced Cervical Cancer

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Paliperidone Palmitate Versus other Antipsychotics for the Treatment of Schizophrenia in France

    Nov 1, 2014, 00:00

  • Assessing the Relationship Between Treatment Effect and Baseline Risk in Network Meta-Analsysis of Moderate to Severe Chornic Plaque Psoriasis Trials

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Posaconazole Versus Fluconazole or Itraconazole in the Prophylaxis of Invasive Fungal Infections Among Neutropenic Patients in Thailand

    Nov 1, 2014, 00:00

  • The Performance- Volume Limit Decreased the DRG Based Acute Care Hospital Financing in hungary

    Nov 1, 2014, 00:00

  • Instructions for Authors

    Nov 1, 2014, 00:00

  • Health Implications of the MTM Eligibility Criteria In The Affordable Care Act Across Racial And Ethnic Groups

    Nov 1, 2014, 00:00

  • Persistence in Open and Closed Data Sources- A Study of Fingolimod Verse Interferons/Glatiramer Acetate in Patients with Multiple Sclerosis

    Nov 1, 2014, 00:00

  • Efficacy and Safety of Five New Antidepression Drugs A Network Meta Analysis

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Fulvestrant in the Treatment of Metastatic Breast Cancer in Second-Line Chemotherapy

    Nov 1, 2014, 00:00

  • Role of Corticosteroids Use in Ards- Comparison of Systematic Review and Meta-Analysis

    Nov 1, 2014, 00:00

  • Belimumab for the Treatment of Systemic Lupus Erythematosus (Sle) In Gree A Cost-Effectiveness and Cost-Utility Analysis

    Nov 1, 2014, 00:00

  • Health-Related Quality of Life Among Tuberculosis Patients in Pakistan- A Cross Sectional Study Using WHOQOL-BREF

    Nov 1, 2014, 00:00

  • Resource Use and Health Care Costs of Cervical Lesions and Cervical Cancer in Slovakia

    Nov 1, 2014, 00:00

  • Burden of Drug Waste in Oncology- Optimization of Resource Use

    Nov 1, 2014, 00:00

  • A Systematic Review of Health State Utility Values for Advanced Ovarian Cancer

    Nov 1, 2014, 00:00

  • Real World Management and Costs in Unresectable Metastatic Melanoma (UMM) Patients Treated at the Antwerp University Hospital (UZA)

    Nov 1, 2014, 00:00

  • Which Metric To Choose For Indirect Comparison Of Treatments When Multiple Comparisons Are Feasible- Lubiprostone Verse Prucalopride In Chronic Constipation

    Nov 1, 2014, 00:00

  • Market Analysis in Regard to Biologically Active Supplements And Medicines in Armenia

    Nov 1, 2014, 00:00

  • Meta-Analysis of Decision Impact and Net Decision Change in Adjuvant Chemotherapy Allocation in Early Stage Node-Negative, Estrogen Receptor-Positive Breast Cancer with a 21-Gene Assay

    Nov 1, 2014, 00:00

  • Trends in Secondary Care Costs for Treatment of Head and Neck Cancer in England

    Nov 1, 2014, 00:00

  • Assessing the Effectiveness AND Cost-Effectiveness of Audit and Feedback on Physician's Prescribing Indicators

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis In Romania

    Nov 1, 2014, 00:00

  • Health Economic Models in Alzheimer's Disease- A Critical Assessment

    Nov 1, 2014, 00:00

  • Are Prices of Patent-Protected Pharamceuticals in the Top 5 Eu Countries Converging?

    Nov 1, 2014, 00:00

  • Treatment Satisfaction In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With Pact-Q2 At Baseline And 12-Month Follow-Up- Prefer In Af Registry

    Nov 1, 2014, 00:00

  • The Cost of Costing Treatments Incorrectly- Errors in the Application of Drug Prices in Economic Models Due to Differing Patient Weights

    Nov 1, 2014, 00:00

  • Cost of Health Care Services Offered by Parkinson Disease Associations in Spain

    Nov 1, 2014, 00:00

  • Long-Term Cost-Effectiveness Of Biphasic Human Insulin 30 In People With Type 2 Diabetes With Inadequate Glycaemic Control On Oral Antidiabetic Drugs In China

    Nov 1, 2014, 00:00

  • Towards Integration of Research Evidence on Patient Preferences in Coverage Decisions and Clinical Practice Guidelines- A Proposal for A Taxonomy of Preference-Related Terms

    Nov 1, 2014, 00:00

  • New Observer-Reported Outcomes To Measure Treatment Satisfaction, Compliance, Palatability, and Gi Symptoms for Patients Needing Iron-Chelation Therapy

    Nov 1, 2014, 00:00

  • Non-Interventional Research Ethical Requirements in England and Fran Shared Experience From A Binational Research Project

    Nov 1, 2014, 00:00

  • A Systematic Review of Methods to Assess the Economic Impact of Air Pollution

    Nov 1, 2014, 00:00

  • High BMI and Belly fat Correlate with Prevalence of Hypertension And Diabetes- A Cross Sectional Study In Sedentary Urban Popultaion Of Delhi

    Nov 1, 2014, 00:00

  • The Effectiveness and Safety of Febuxostat - An Experience in Medical Center in Taiwan

    Nov 1, 2014, 00:00

  • A Cost-Analysis of Complex Radiotherapy in Patients with Head and Neck Cancer Results from the Art-Orl Study

    Nov 1, 2014, 00:00

  • How do Organizational Arrangements of the Pharmaceutical Supply System Affect Availability to Essential Medicines in Rural China?

    Nov 1, 2014, 00:00

  • Quasi-Monte Carlo Simulation and Variance Reduction Techniques Substantially Reduce Computational Requirements of Patient-Level Simulation Models- an Application to a Discrete Event Simulation Model

    Nov 1, 2014, 00:00

  • Burden of Varicella in Asia-Pacific Countries- A Systematic Review and Critical Analysis

    Nov 1, 2014, 00:00

  • Nuedexta for the Treatment of Pseudobulbar Affect- Estimating the Financial Impact to the Scottish NHS

    Nov 1, 2014, 00:00

  • The Cost Burden of Community-Acquired Pneumonia in Russia in Adults of 50 and Older- A Regional Study and National Estimates

    Nov 1, 2014, 00:00

  • Cost-Effectiveness And Budget Impact Analyses Of Risk Stratification Of Patients With Moderate Risk Of Cardiovascular Events Using Lp-Pla2 Testing

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Dapagliflozin In Combination With Insulin for the Treatment of Type 2 Diabetes Mellitus (T2dm) In Spain

    Nov 1, 2014, 00:00

  • Impacts of Epro Data Collection Mode Selection on Patient Inclusion

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of Crizotinib Treatment In Alk+ Non-Small-Cell Lung Cancer Patients In Thailand

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness Of Dabigatran Etexilate Compared With Warfarin And Rivaroxaban In The Treatment Of Acute Pulmonary Embolism In The Uk

    Nov 1, 2014, 00:00

  • Real-World Cost-Utility Evaluation of Multiple Myeloma Treatments In Stem Cell Transplanted Patients

    Nov 1, 2014, 00:00

  • The Importance of Long-Term Surveillance of Stage IB Melanomas- Unexpectedly Low Survival Subsequent to Recurrence

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of Hypertensive Treatment With Indapamide And Amlodipine Single-Pill Combination In The Polish Setting

    Nov 1, 2014, 00:00

  • The Economic Value of Vaccination- Why Prevention Is Wealth

    Nov 1, 2014, 00:00

  • Pharmaceutical Market Access in Emerging Markets Through Innovative Patient Access Schemes

    Nov 1, 2014, 00:00

  • Economic Burden of Major Depressive Disorder (Mdd) in Five European Countries- Description of Resource use by Health State

    Nov 1, 2014, 00:00

  • A Cost-Consequence Analysis of Human Papillomavirus Vaccination in Romania

    Nov 1, 2014, 00:00

  • Clinical and Demographics Characteristics of Non-Valvular Atrial Fibrillation Patients Switching From Warfarin To Novel Oral Anticoagulants

    Nov 1, 2014, 00:00

  • Cost Minimization Analysis Of Clinical Option Scenarios For Metformin And Acarbose In Treatment Of Type 2 Diabetes- Based On Direct And Indirect Treatment Comparison Results

    Nov 1, 2014, 00:00

  • What are the Key Driving Factors Behind RSA Decisions In Australia?

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Ranibizumab Versus Photodynamic Therapy for the Treatment of Neovascluar Age-Related Macular Degeneration Based in China Cost Setting

    Nov 1, 2014, 00:00

  • Knowledge of Human Papillomavirus among University Students in Hungary

    Nov 1, 2014, 00:00

  • Health State Utilities for Pressure Ulcers – A Comparison of Condition-Specific and Generic Measures and Time-Trade-Off (Tto)

    Nov 1, 2014, 00:00

  • Resources Utilization for the Investigation of Pulmonary Nodules in a University Hospital Center in Quebec, Canada

    Nov 1, 2014, 00:00

  • Value in the Making- Harvesting the Value of Complex Medical Innovations in Practice

    Nov 1, 2014, 00:00

  • Economic Evaluation of Home Parenteral Nutriton in Cancer Patients; The French Context

    Nov 1, 2014, 00:00

  • Health Related Quality of Life in Cancer Patients- Evaluation With A Self-Administered Ipad Application

    Nov 1, 2014, 00:00

  • Quality of Life Decrements after Stroke

    Nov 1, 2014, 00:00

  • The Benefits and Challenges of Submitting to the Nice Medical Technologies Evaluation Programme-Manufacturer Perceptions And Experiences

    Nov 1, 2014, 00:00

  • Ldl-C Lowering Efficacy of Evolocumab (Amg 145) Could Reduce Apheresis in Patients At High Risk for Cardiovascular Events in Germany

    Nov 1, 2014, 00:00

  • Comparing Access to Drugs Through the CDF and by Nice – The CDF Stipulate Stricter Clinical Criteria but will Also Approve Funding for Off-Label Usage

    Nov 1, 2014, 00:00

  • Lipid Control After Percutaneous Coronary Intervention (PCI) in China

    Nov 1, 2014, 00:00

  • Can Using a Resource Use Log in an Economic Evaluation Alongside a Randomised Controlled Trial Reduce the Amount of Recall Bias?

    Nov 1, 2014, 00:00

  • Assesment Of Serial Transverse Enteroplasty- Systematic Review

    Nov 1, 2014, 00:00

  • Care Needs for Rheumatoid Arthritis from Patient Perspectives- A Qualitative Study from Singapore General Hospital

    Nov 1, 2014, 00:00

  • Evidence-Based Medicine as a Driver of Improving Colorectal Cancer Screening in Ukraine

    Nov 1, 2014, 00:00

  • A Systematic Search and Methodological Review of Economic Models of Analgesics for Chronic Pain

    Nov 1, 2014, 00:00

  • UK Value-Based Assessment- Will Scotland's Smc Approach It In The Same Way?

    Nov 1, 2014, 00:00

  • Trends in Physical and Occupational Therapy Utilziation in the Us And Western Europe

    Nov 1, 2014, 00:00

  • Supporting Interoperable Eu Patient Registries- Survey of Registry Holders' Needs

    Nov 1, 2014, 00:00

  • Predictors of Working Motivation in Job Satisfaction Among Nurses in Cyprus

    Nov 1, 2014, 00:00

  • Potentially Inappropriate Medication in the Elderly – Relevance and Economics of the 30 Top-Selling Priscus Agents in Germany

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of the Lidocaine 5% Medicated Plaster Verse Pregabalin and Amitriptyline for the Treatment of Post-Herpetic Neuralgia In the Netherlands

    Nov 1, 2014, 00:00

  • The Impact of Cost Containment Reforms to the Pharmaceutical Benefits Scheme (Pbs) On Prescribing Volumes And Expenditure In Australia- 1992 To 2011

    Nov 1, 2014, 00:00

  • The Determinants of Uptake and Diffusion of Innovative Health Technologies. An Empirical Analysis

    Nov 1, 2014, 00:00

  • Do Specialty Drugs Offer Greater Value for Money Than Traditional Drugs?

    Nov 1, 2014, 00:00

  • How Successful Have Pediatric Investigation Plans Been In Stimulating Research For Pediatric Cancers?

    Nov 1, 2014, 00:00

  • Early Cost-Effectiveness Modeling for Tumor Infiltrating Lymphocytes (TIL) -Treatment Versus Ipilimumab in Metastatic Melanoma Patients

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of a Shingles Vaccination Program to Prevent Herpes Zoster And Post- Herpetic Neuralgia in the Spanish Setting

    Nov 1, 2014, 00:00

  • Best Practices and Key Challenges in Cost-Effectiveness Modelling of Multiple Sclerosis Therapies

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of Mycophelonate Sodium On Patients With Renal Transplant At The Public Mexican Health Care System

    Nov 1, 2014, 00:00

  • Design Methods For Study Of Prevalence, Risk Factors And Economic Burden Of Insulin Injection-Related Lipohypertrophy In China

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Lenalidomide-Plus-Dexamethasone in Multiple Myeloma Patients Who Have Received at Least One Prior Therapy- A South Korean Perspective

    Nov 1, 2014, 00:00

  • Data Sources of Disease Epidemiology in German Drug Reimbursement Dossiers- Case Study Of Diabetes Mellitus Type II

    Nov 1, 2014, 00:00

  • Relative Efficacy And Safety of Ustekinumab Compared to Anti-TNF-Alfa Therapies in Patients With Active Psoriatic Arthritis

    Nov 1, 2014, 00:00

  • Implementation of Technologies Based on the Evidence-Based Medicine and Hta in the Management of Hepatitis C

    Nov 1, 2014, 00:00

  • Patient-Reported Outcomes of Dipeptidyl Peptidase-4 Inhibitors- A Systematic Review

    Nov 1, 2014, 00:00

  • Economic Burden of Pediatric Atopic Dermatitis in Asia-Pacific- A Review of the Literature

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Etanercept in the Treatment of Rheumatoid Arthritis In Portugal

    Nov 1, 2014, 00:00

  • The Efficiency Evaluation of the Rule From Drug Market Regulation Chamber (Cmed) Proposed To Public Medicines Acquisitions

    Nov 1, 2014, 00:00

  • Evaluating Rates of Potential Generic Substitution for Prescription Drugs- Can We Improve On Existing Incentive Schemes?

    Nov 1, 2014, 00:00

  • A Comparison of Factors Influencing Reimbursement and Coverage Decisions in Scotland (Smc), The Netherlands (Nzi) and Germany (G-Ba)

    Nov 1, 2014, 00:00

  • Systematic Review and Mixed Treatment Comparison of Lithium or an Atypical Anti-Psychotic (AAP) used to Augment a Selective Serotonin Reuptake Inhibitor (SSRI) in Treatment Resistant Depression (TRD)

    Nov 1, 2014, 00:00

  • Using the Analytic Hierarchy Process To Derive Health State Utilities From Ordinal Preference Data

    Nov 1, 2014, 00:00

  • ESTIMATED ECONOMIC BURDEN OF INSULIN INJECTION-RELATED LIPOHYPERTROPHY IN CHINESE PATIENTS WITH DIABETES

    Nov 1, 2014, 00:00

  • Development And Content Validity Testing Of A Treatment Acceptance Measure For Use In Hypercholesterolemia Patients Receiving Treatment Via Subcutaneous Injection

    Nov 1, 2014, 00:00

  • Modeled Outcomes and Overall Costs of the 13-Valent Pneumococcal Conjugate Vaccine in the Tunisian National Vaccination Program

    Nov 1, 2014, 00:00

  • Health-Related Quality of Life in Italian Patients With Moderate and Severe Crohn's Disease- Interim Results from the Sole Study

    Nov 1, 2014, 00:00

  • Applying Multiple Criteria Decision Analysis in the Context of Health Technology Assessement- an Empirical Case Study

    Nov 1, 2014, 00:00

  • Health State In Patients With Venous Thromboembolism On Conventional And Non-Vka Oral Anticoagulants As Assessed With The Eq-5d-5l Questionnaire- Prefer In Vte Registry

    Nov 1, 2014, 00:00

  • Trends in Time To Market Access In Europe - Is It Getting Better?

    Nov 1, 2014, 00:00

  • Market Access and Reimbursement- The Increasing Role of Real-World Evidence

    Nov 1, 2014, 00:00

  • The Burden Of Chronic Urticaria In Europe- A Systematic Literature Review

    Nov 1, 2014, 00:00

  • Expert Elicitation Used for Early Technology Assessment to Inform on Cost-Effectiveness of Next Generation Sequencing

    Nov 1, 2014, 00:00

  • Choosing Important Health Outcomes For Comparative Effectiveness Research- A Systematic Review

    Nov 1, 2014, 00:00

  • Patient Specific Landscape of Information Technology Solutions for Diabetes Self-Management

    Nov 1, 2014, 00:00

  • Will Value Based Assessment (VBA) Revolutionise The Nice Assessment?

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Assessment Of Apixaban Versus Standard Of Care For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation Patients

    Nov 1, 2014, 00:00

  • Determination Of The Annual Health Insurance Cost Of Outpatient Care Physiotherapy Services For Low Back Pain

    Nov 1, 2014, 00:00

  • Mapping from SF-6D to EQ-5D- Changes in Estimates Based on the Choice of Algorithm

    Nov 1, 2014, 00:00

  • Methods for Health Economic Evaluations of Vaccines – Results from an International Expert-Workshop

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness Threshold For Orphan Designations in Poland Based on Reimbursement Decisions

    Nov 1, 2014, 00:00

  • Budget impact analysis of peritoneal dialysis versus. Conventional in-center hemodialysis in malaysia

    Nov 1, 2014, 00:00

  • Will Nurses Have Better Outcomes than Non-Medical Working Women when Hospitalized for Female Genital Diseases?

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Vismodegib Verse Standard of Care Therapy in the Treatment of Locally-Advanced or Symptomatic Metastatic Basal Cell Carcinoma in Hungary – A Global Cost-Effectiveness Model Adaptation

    Nov 1, 2014, 00:00

  • Inpatient Case-Related Treatment Costs For Different Cardiovascular Diseases In Germany

    Nov 1, 2014, 00:00

  • Cost-Effectiveness and Long-Term Outcomes of Sovaldi (SOFOSBUVIR) for the Treatment of Chronic Hepatitis C Infected (HCV) Patients from a Swedish Societal Perspective

    Nov 1, 2014, 00:00

  • Differences Between Hypothetical and Experience-Based Value Sets for Eq-5d- Implications for Decision Makers

    Nov 1, 2014, 00:00

  • Modification of Patient Reported Outcomes Measures of Compliance, Gastrointestinal Symptoms, Palatability and Treatment Satisfaction for Patients Needing Iron Chelation therapy

    Nov 1, 2014, 00:00

  • Health Economic Evaluation of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in France

    Nov 1, 2014, 00:00

  • A Systematic Literature Review on Risk Factors for Cervical Cancer in Chinese Population

    Nov 1, 2014, 00:00

  • Multi-Criteria Decision Analysis for Reimbursing Orphan Drugs- A Dutch Demonstration Study Using the Analytic Hierarchy Process Method

    Nov 1, 2014, 00:00

  • Knowledge of HIV Status of Adolescents and Young Adults Attending an Adolescent HIV Clinic in Accra, Ghana

    Nov 1, 2014, 00:00

  • Survey Findings on Evaluation of Traumatologist's Workload in Mongolia

    Nov 1, 2014, 00:00

  • The Life and Death of the End of Life Treatment Appraisal Criteria in Nice Technology Appraisals?

    Nov 1, 2014, 00:00

  • Hta Epidemiology Data in Different Geographical Regions- Investigation of Requirements For Oncology Drugs

    Nov 1, 2014, 00:00

  • Indirect Costs of Diabetes Mellitus (Dm) From the Perspective of The Social Insurance Institution (Zus) In Poland

    Nov 1, 2014, 00:00

  • HTA Informed Price Negotiations- Cost Savings To The Health Payer in Ireland

    Nov 1, 2014, 00:00

  • The Long-Term Outcomes Of Bariatric Surgery On Patients With Type 2 Diabetes Mellitus- A Systematic Review And Meta-Analyses

    Nov 1, 2014, 00:00

  • Development of a Longitudinal National Football League Injury and Injury Impacts (L-NFL-III) Database

    Nov 1, 2014, 00:00

  • The Comparison of the Risk-Sharing Schemes Proposed in Reimbursement Applications Received By Ahtapol In 2012 and 2013

    Nov 1, 2014, 00:00

  • The Cost Comparison Of Drug-Eluting Stents (Des) And Bare-Metal Stents (Bms) - A Retrospective Cohort Matched Study

    Nov 1, 2014, 00:00

  • Quality of Diabetes Care Among Obese and Overweight Patients at Nhg Polyclinics

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Tocilizumab Verse Infliximab for the Patients With Rheumatoid Arthritis in Kazakhstan

    Nov 1, 2014, 00:00

  • An Indirect Treatment Comparison of Cabozantinib Verse Vandetanib in Progressive Medullary Thyroid Cancer (MTC)

    Nov 1, 2014, 00:00

  • Impact of 2011 German Health Care Reform on Prices

    Nov 1, 2014, 00:00

  • The Impact Of Daytime And Nocturnal Non-Severe Hypoglycaemic Events On People With Diabetes In Turkey

    Nov 1, 2014, 00:00

  • Economic Evaluation of Agomelatine for Major Depressive Disorders Relative to other Antidepressants in the Italian Setting

    Nov 1, 2014, 00:00

  • Guidance For Economic Evaluation and Budget Impact Analysis For Pharmaceuticals in Catalonia (Spain)

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of High-Sensitive Troponin Assays For The Early Rule-Out Or Diagnosis Of Acute Myocardial Infarction (Ami) In People With Acute Chest Pain- A Nice Diagnostic Assessment

    Nov 1, 2014, 00:00

  • Prescription of Rosiglitazone and Pioglitazone Folowing Safety Warnings- A Comparative Analysis of Trends in Dispensing Patterns in Denmark and Germany From 2007 To 2013

    Nov 1, 2014, 00:00

  • Use Of External Data To Guide Long-Term Survival Extrapolations Of Trial Data For Chronic Lymphocytic Leukemia

    Nov 1, 2014, 00:00

  • Financial and Clinical Implications of Intramuscular Versus Subcutaneous Interferon Beta-1a in Portugal, Based on the Findings from the Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2014, 00:00

  • What is the Status of Health Related Quality of Life Among Medical Representatives in India?

    Nov 1, 2014, 00:00

  • Letting The Data Speak- A Shift of the Pharmaceutical Spending to Households in Greece

    Nov 1, 2014, 00:00

  • Hearing the Patient's Voice in Health Care- A Survey Analysis of Patients' Perceptions of Difficulties in Shared Clinical Decision-Making

    Nov 1, 2014, 00:00

  • Understanding Caregiver Burden in Colorectal Cancer- What Role Do Patient And Carer Factors Play?

    Nov 1, 2014, 00:00

  • Avoiding and Identifying Errors and Other Threats To the Credibility of Health Economic Models

    Nov 1, 2014, 00:00

  • Analyses on Temporal and Spatial Clustering and Changing Trend of HCV in Mainland of China

    Nov 1, 2014, 00:00

  • Cognitive Function And Non-Adherence To Antihypertensive Medications

    Nov 1, 2014, 00:00

  • A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Antiviral Therapy for Chronic Hepatitis B- A Systematic Review

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Ustekinumab Compared With Etanercept for the Treatment of Moderate to Severe Psoriasis in Costa Rica

    Nov 1, 2014, 00:00

  • Effectiveness of Heavy-Light Chain Quantitative Test- A Systematic Review

    Nov 1, 2014, 00:00

  • Ten Years Of Development Studies In Health Technology Assessment In Brazil- Profile Of Studies And Operational Indicators

    Nov 1, 2014, 00:00

  • National Rare Disease Strategies- The Current State for Orphan Drug Market Access in European Union (Eu) Member States

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of A Short Message Service (Sms) Intervention To Prevent Type 2 Diabetes Among Adults With Impaired Glucose Tolerance

    Nov 1, 2014, 00:00

  • Hospitalization Costs Associated With Liver Cirrhosis

    Nov 1, 2014, 00:00

  • Measuring and Observing Positive And Negative Externalities Caused By Vaccines- Do We Have The Right Assessment Approach Available?

    Nov 1, 2014, 00:00

  • Assessment of Medication Adherence in Rheumatoid Arthritis Patients in a Tertiary Care Hospital

    Nov 1, 2014, 00:00

  • Impact of Economic Crisis on the Greek Health Care System and on the Population Health

    Nov 1, 2014, 00:00

  • Quality of Life in Patients With Axial Spondyloarthritis in Clinical Practice In Sweden- Baseline Results From A Longitudinal Study

    Nov 1, 2014, 00:00

  • Reimbursement Decisions in Oncology Drugs- An International Analysis

    Nov 1, 2014, 00:00

  • Medication Counseling Beyond Instituitional- Impact Of Pharmacist-Led Home Medication Review In Type 2 Diabetes Patients

    Nov 1, 2014, 00:00

  • Assesing the Impact of Patent Loss on Overall Revenues and Stocks Price of Pharmaceutical Companies

    Nov 1, 2014, 00:00

  • Non-Steroidal Anti-Inflammatory Drugs in Household Drug Supplies in Serbia

    Nov 1, 2014, 00:00

  • A Budget Impact Analysis (Bia) Of The Use Of Paricalcitol For The Treatment Of Secondary Hyperparathyroidism (Shpt) In End Stage Renal Disease Patients

    Nov 1, 2014, 00:00

  • Guidance for Risk Sharing Agreements / Pay Per- Results SCHEMES FOR PHARMACEUTICALS IN CATALONIA (SPAIN)

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of the Treatment of Respiratory Diseases of Xiyanping Injection - A Systematic Review

    Nov 1, 2014, 00:00

  • Racial Disparities in Type 2 Diabetes Health Care Utilization in Medicaid Adults With Developmental Disabilities

    Nov 1, 2014, 00:00

  • Prevalence of Chronic Diseases Among Older Patients (>65 Years) in German General Practitioner Practices

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Colonic Stents for the Management of Malignant Large Bowel Obstruction

    Nov 1, 2014, 00:00

  • What is the Most Cost-Effective Strategy for Treating Chronic Myeloid Leukemia After Imatinib Loses Patent Exclusivity in Europe?

    Nov 1, 2014, 00:00

  • Predictors For Mortality Among Human Immunodeficiency Virus Infected Patients On Antiretroviral Therapy

    Nov 1, 2014, 00:00

  • Predictive Modelling- Predicting Hospitalisation And Estimating The Cost And Risk To The Third Party Funder

    Nov 1, 2014, 00:00

  • Cost and Burden Of Hypercholesterolemia In Portugal

    Nov 1, 2014, 00:00

  • Validity of the Eq-5d-5l in Stroke Patients

    Nov 1, 2014, 00:00

  • A Kinematic Comparison of Overground and Treadmill Walking

    Nov 1, 2014, 00:00

  • Estimating Overall Impact of Human Papillomavirus Vaccination on Cervical Cancer Burden in Spain and Portugal

    Nov 1, 2014, 00:00

  • Antidepressant use and Suicide Rate in England- the Geographic Divide

    Nov 1, 2014, 00:00

  • Predictive Modeling to Assess Predictors of Treatment Success and Failure Among Combination Statin Therapy Patients

    Nov 1, 2014, 00:00

  • Prescribing Patterns of General Practitioners (Gps) in Primary Health Care- Evidence From Greece

    Nov 1, 2014, 00:00

  • Development And External Validation Of A Risk Calculator For Predicting Anemia In Patients Treated With Triple Therapy (Tt) Containing Boceprevir (Boc), Pegylated Interferon And Ribavirin (Pr)

    Nov 1, 2014, 00:00

  • Aripiprazole Once-Monthly is a Cost-Effective Therapeutic Option in the Maintenance Treatment of Schizophrenia- Results from a Markov Model

    Nov 1, 2014, 00:00

  • Comparison of Epidemiology and Drug Treatment in HER2 Negative Metastatic Breast Cancer (MBC) in EU5

    Nov 1, 2014, 00:00

  • Drug Access Through Sharing Public And Individual Responsibilities In The Public Health Care System Of Singapore

    Nov 1, 2014, 00:00

  • Functional Impairment and Cognitive Dysfunction in Depressed Patients in South-Korea- Results of Perform-K

    Nov 1, 2014, 00:00

  • Efficacy of Treatments for Macular Oedema Secondary to Branch Retinal Vein Occlusion- A Network Meta-Analysis

    Nov 1, 2014, 00:00

  • Direct Non-Medical Costs Of Rheumatoid Arthritis By Disease Level In Portugal

    Nov 1, 2014, 00:00

  • Assessing The Relationship Between Individual Attributes Identified In Review Of Multi-Criteria Decision Analysis (MCDA) Of Rare Diseases And Annual Treatment Costs In Rare Endocrine Disorders

    Nov 1, 2014, 00:00

  • Work Productivity Improvement Associated With Apremilast, An Oral Phosphodiesterase 4 Inhibitor, in Patients With Psoriatic Arthritis Results Of A Phase 3, Randomized, Controlled Trial

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis Of An Antimicrobial Transparent Dressing For Protecting Central Vascular Accesses In Critically Ill Patients Versus Standard Transparent Dressings In Fran A Comparison Of Two Modeling Approaches- Decision-Tree Ve ...

    Nov 1, 2014, 00:00

  • Validation of the Adherence Barriers Questionnaire (Abq) – An Instrument for Identifying Potential Risk Factors Associated With Medication-Related Non-Adherence

    Nov 1, 2014, 00:00

  • Qualitative Assessment of the Quality of Pharmaceutical Care Services in the Province of Khyber Pakhtunkhwa, Pakistan- Hospital Pharmacists' Views

    Nov 1, 2014, 00:00

  • Risk of Bias in Trial-Based Economic Evaluations

    Nov 1, 2014, 00:00

  • Fidaxomicin Therapy for Patients with Clostridium Difficile Infection- A Systematic Literature Review and Meta-Analysis

    Nov 1, 2014, 00:00

  • Prevalence of Metabolic Syndrome in Patients with Schizophrenia According to the Presence or Absence of Negative Symptoms

    Nov 1, 2014, 00:00

  • The Impact Of Diabetes On Mortality In Inpatients From Medical Department Of A Chinese Tertiary Hospital

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of 2-DOSE AS04-Adjuvanted Human Papillomavirus 16/18 Vaccination Schedule in Slovakia

    Nov 1, 2014, 00:00

  • Calculating Indirect Costs – Differences Caused by Various Approaches to Unit Costs. Results of Move to Work Study (M2W)

    Nov 1, 2014, 00:00

  • Price Comparison in the European Pharmaceutical Market

    Nov 1, 2014, 00:00

  • Premixed Insulin Lispro Versus Insulin Glargine In Type 2 Diabetes- A Meta-Analysis

    Nov 1, 2014, 00:00

  • A Prospective, Cross-Sectional Study On Cost And Adherence Of Antidiabetic Prescriptions At A Tertiary Care Teaching Hospital In South India

    Nov 1, 2014, 00:00

  • Health Economic Evaluation of Guangdong Rural Tertiary Breast Cancer Screening and Diagnosis System

    Nov 1, 2014, 00:00

  • Cost Effectiveness Of Renal Denervation Therapy For The Treatment Of Resistant Hypertension In The Netherlands

    Nov 1, 2014, 00:00

  • German Patients' Preferences for Attributes Of Type 2 Diabetes Medications

    Nov 1, 2014, 00:00

  • Analysis of Factors Causing Chronic Obstructive Pulmonary Disease in Eastern Region of China

    Nov 1, 2014, 00:00

  • Economic Evaluation Of Ferric Carboxymaltose In Patients With Chronic Heart Failure And Iron Deficiency- An Analysis For Greece Based On Fair-Hf Trial

    Nov 1, 2014, 00:00

  • Acute And Chronic Impact Of Cardiovascular Events On Health State Utilities

    Nov 1, 2014, 00:00

  • A DE-NOVO Model to Predict Outcomes of a New Hypothetical Intervention to Reduce CV Risk in Post Mi Patients

    Nov 1, 2014, 00:00

  • A Chart Abstraction Based Method to Classify Real World Patients With Pulmonary Arterial Hypertension Based on Who Functional Classification

    Nov 1, 2014, 00:00

  • Change in Percentage of Left Ventricular Ejection Fraction in Breast Cancer Patients Received Trastuzumab Treatment

    Nov 1, 2014, 00:00

  • The Grass is Always Greener on the Other Side or Why There Is Little Meaning in International Pharmaceutical Price Comparison

    Nov 1, 2014, 00:00

  • Boosting Biosimilars Uptake in European Countries

    Nov 1, 2014, 00:00

  • Preferences Regarding The Attributes Of Oral Anticoagulants In Patients With Atrial Fibrillation Results Of A Discrete Choice Experiment

    Nov 1, 2014, 00:00

  • Economic Evaluation of Nalmefene for the Treatment of Alcohol Dependence in Greece

    Nov 1, 2014, 00:00

  • Overall Survival in Patients with HER2+ Early Stage Breast Cancer Patients Treated with Trastuzumab in the US Department of Defense Practice Setting

    Nov 1, 2014, 00:00

  • Demographics And Health Outcomes Associated With Adherence And Non-Adherence Among Type2 Diabetics In China

    Nov 1, 2014, 00:00

  • Bortezomib Re-treatment in Patients with Multiple Myeloma (MM). A Real World Medical Practice Experience from a Swedish National Registry

    Nov 1, 2014, 00:00

  • Joint Modeling of Primary and Secondary Non-Adherence Outcomes

    Nov 1, 2014, 00:00

  • Should Cost-Effectiveness Analysis Include The Cost Of Consumption Activities? An Empirical Investigation

    Nov 1, 2014, 00:00

  • An Ethic System Overview- Brazilian Perspectives For Observational Studies

    Nov 1, 2014, 00:00

  • The Impact of the Income Per Capita in Chinese Family on Medical Expenditure

    Nov 1, 2014, 00:00

  • Modelling Longitudinal Trajectories of Patient-Reported Outcomes To Evaluate Treatment Effect

    Nov 1, 2014, 00:00

  • Drug Access Is Improved By The Essential Drug System And “Low-Priced Drug” Policy In China

    Nov 1, 2014, 00:00

  • A Model to Estimate the Health System Burden of Prescription Opioid Abuse in Europe

    Nov 1, 2014, 00:00

  • Patients' Acceptance of Their Medication- Results From a French Multi-Diseases Study With Patient Online Community Using the Acceptance By the Patients of Their Treatment (Accept©) Questionnaire

    Nov 1, 2014, 00:00

  • Systematic Review of Observational Studies and Rcts of Omalizumab in Severe Persistent Allergic Asthma and Meta-Analysis Feasibility Assessment

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness Analysis of Two Pegylated Interferon ALFA Treatment for Chronic HCV Infection in China

    Nov 1, 2014, 00:00

  • Assessment Of The Huntington Quality Of Life Instrument (H-QOL-I) Cross-Cultural Validity

    Nov 1, 2014, 00:00

  • Mapping May Cause Straining- The Inconsistent Relationship Between A Disease- Specific Questionnaire (Pac-Qol) And Eq-5d Mapping In Constipation

    Nov 1, 2014, 00:00

  • In-Patient Hospital Costs of Stroke- A Focused Literature Review

    Nov 1, 2014, 00:00

  • The Selection of Appropriate Health State Utility Values (Hsuvs) for Health Technology Assessment (Hta)- Lessons To Be Learnt

    Nov 1, 2014, 00:00

  • The Lumley-Method, A Recommended Network Meta-Analysis for Indirect Comparisons, Summarized for Practitioners

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Interventions Aimed at Decreasing The Number of Amputations Among Patients With Diabetes Mellitus

    Nov 1, 2014, 00:00

  • Resource Use and Health Care Costs of Chronic Obstructive Pulmonary Disease in Slovakia

    Nov 1, 2014, 00:00

  • Clinical Outcome Assessment (Coa) Instrument Scoring- the Validity and Precision of Unweighted Summary Scores Verse Irt Weighted Scores, and the Added Value of Irt Standard Errors

    Nov 1, 2014, 00:00

  • Drug Utilization Pattern for the Treatment of Septic Shock in the ICU- A Comparison Between Survivors and Non-Survivors in a Tertiary Care Teaching Institute

    Nov 1, 2014, 00:00

  • Product Quality Aspect in Reimbursement of Medical Devices- Comparison of Turkey Verse Europe

    Nov 1, 2014, 00:00

  • Availability of Risk Sharing Agreements in the Turkish Pharmaceutical Sector

    Nov 1, 2014, 00:00

  • WX-III-287-19 A Possible Thromboxane Antagonist in Bovine Coronary Arteries

    Nov 1, 2014, 00:00

  • Setting Targets For Public Spending Under Eu-Imf Assistance To Portugal - The Case Of Health Care and Pharmaceuticals

    Nov 1, 2014, 00:00

  • The Development and Preliminary Validation of the Manchester Early Morning Symptoms Index (Memsi) for People With Chronic Obstructive Pulmonary Disease (Copd)

    Nov 1, 2014, 00:00

  • Saving Money in Health Care- Cost Effectiveness of Individual Drugs (As By Nice) Or Budget Cuts (As Under Pprs)?

    Nov 1, 2014, 00:00

  • Clinical and Economic Analysis of Effectiveness of Everolimus in the Treatment Of HR+, HER2- Advanced Breast Cancer in Russia

    Nov 1, 2014, 00:00

  • The Medical Costs of Chronic Obstructive Pulmonary Disease in South Korea

    Nov 1, 2014, 00:00

  • An Italian Oncology Research to Evaluate Adherence to Clinical Guidelines for Cancer Treatment- The Right Program

    Nov 1, 2014, 00:00

  • Collaborative Approach in Accessing Homogeneous Medical Data in Grid-Based Environment (Enhancing Diseases Classification)

    Nov 1, 2014, 00:00

  • Ten Years Outcomes in a Cohort of Patients Started on Antiretroviral Treatment in an Urban Clinic in Sub-Saharan Africa

    Nov 1, 2014, 00:00

  • Awareness of Hyperlipidemia Among University Students and Staff Member

    Nov 1, 2014, 00:00

  • Are Patient Reported Outcomes Relevant To Patients? Learnings From A Patient Advocate Survey

    Nov 1, 2014, 00:00

  • Pharmacy Cost Calculator for Hepatitis C Virus Patients in Turkey

    Nov 1, 2014, 00:00

  • Initial Inappropriate Antibiotic Therapy in Hospitalized Patients with Gram-Negative Infections- Systematic Review And Meta-Analysis

    Nov 1, 2014, 00:00

  • Health Care use and Oral Medication Patterns for Type 2 Diabetes Patiets in China：The Role of Traditional Chinese Medicines

    Nov 1, 2014, 00:00

  • How Does Non-Malignant Opioid Induced Constipation (Oic) Impact Health State Utility?

    Nov 1, 2014, 00:00

  • Clinical Trials in Fran An Underexploited Opportunity

    Nov 1, 2014, 00:00

  • The Incidence, Prevalence, and Survival of Malignant Melanoma in Taiwan

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis of Dolutegravir Compared to Raltegravir in Treatment Naive and Treatment Experienced Patients in Slovak Settings

    Nov 1, 2014, 00:00

  • Assessing the Comparative Outcomes from Teriflunomide and Dimethyl Fumarate Studies in Relapsing Ms- Use of “Number Needed to Treat” Analysis

    Nov 1, 2014, 00:00

  • Economic Impact of Using Subcutaneous Trastuzumab

    Nov 1, 2014, 00:00

  • Assessment of Rural Health Purchasing Arrangements In China

    Nov 1, 2014, 00:00

  • Comparative Effectiveness Research of Medical Devices – New Methods Needed?

    Nov 1, 2014, 00:00

  • Cost of Pharmacotherapy in Polish Patients With Rheumatoid Arthritis

    Nov 1, 2014, 00:00

  • Payer's Perceptions of Glucagon Kits Aimed at Reducing Administration Complexity During Severe Hypoglycemic Events

    Nov 1, 2014, 00:00

  • Costed Treatment Pathways of Diffuse Large B Cell Lymphoma in a UK Population-Based Cohort- A Patient Level Simulation Model

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Panitumumab Plus Mfolfox6 Versus Bevacizumab Plus Mfolfox6 for First-Line Treatment of Patients with Wild-Type Ras Metastatic Colorectal Cancer

    Nov 1, 2014, 00:00

  • Evidences and Criteria Related to the Hospital Service Quality and Safety

    Nov 1, 2014, 00:00

  • Work Productivity Loss Due To Rheumatoid Arthtiris (Ra), Crohn's Disease (Cd) And Psoriasis (Ps) In Poland

    Nov 1, 2014, 00:00

  • Inadequate Pain Relief Among Patients With Primary Knee Osteoarthritis - Analysis From The Portuguese Sample Of The Survey Of Osteoarthritis Real World Therapies (Sort)

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Modeling Of Antimicrobial Dressings For Preventing Catheter-Related Bloodstream Infection- Homogeneous Verse Non-Homogeneous Markov Approaches

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Ipilimumab for Previously Untreated Patients with Advanced Metastatic Melanoma in Spain

    Nov 1, 2014, 00:00

  • Assessment of the Methodological Quality of Randomized Controlled Trials Published in "Russian Allergology Journal" in 2009-2013

    Nov 1, 2014, 00:00

  • Nice's Proposed Value-Based Assessment of Health Technologies- Concerns of Inconsistent Consideration of Social Values

    Nov 1, 2014, 00:00

  • Uisess-B Oral Health Questionnaire Validity And Reliability In A Mexican Diabetic, Systemic Hypertension And Obese Patients

    Nov 1, 2014, 00:00

  • The Health Economic Impact of Resource use in Dementia- the Erlanger Dementia Registry (EDR)

    Nov 1, 2014, 00:00

  • Long Term Survival of Patients with Various Lung Cancer Histology in Seer Between 2004-2011

    Nov 1, 2014, 00:00

  • Hierarchical Network Meta-Analysis Incorporating Ordering Constraints on Increasing Doses of Interventions - Application to Overactive Bladder Syndrome

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Different Scenarios of Detecting of TB Among HIV-Infected People Depending on CD 4+ Count

    Nov 1, 2014, 00:00

  • Cost Effectiveness of Pentavalent Rotavirus Vaccine (Rv5) in Slovenia

    Nov 1, 2014, 00:00

  • Systematic Review of Economic Evaluations in Cancerology In Brazil Between 1980 And 2013

    Nov 1, 2014, 00:00

  • ARE TOTAL HEALTH CARE EXPENDITURES IMPACTED BY A NEW DIABETES DIAGNOSTIC FACTOR- HBA1C?

    Nov 1, 2014, 00:00

  • Health Related Quality of Life Among Young Smokers

    Nov 1, 2014, 00:00

  • Median Hospitalization Cost and Length of Stay for Carbapenem-Resistant Verse Carbapenem-Sensitive Patients in a Tertiary Care Hospital in South India

    Nov 1, 2014, 00:00

  • Coverage Decision Framework in Asia Pacific- A Case Study of Targeted Cancer Medicines in the Treatment of Breast Cancer

    Nov 1, 2014, 00:00

  • Are Cycles Needed in Markov Models? – The Continuous Model as a Simpler Approach

    Nov 1, 2014, 00:00

  • Regulatory Issues in Pro Advertising- A Review of the Ddmac/Opdp Letters From 1998 To 2013 To Identify Pro Claims Violations and Examine Their Evolution Over Time

    Nov 1, 2014, 00:00

  • The Inverse Correlation Between Internal And External Risk Under International Reference Pricing- An Analysis of Six European Countries

    Nov 1, 2014, 00:00

  • Do new cancer drugs offer good value for money? the perspective of oncologists, payers, patients, and general population

    Nov 1, 2014, 00:00

  • Survey of Treatment Costs to Hepatitis C in China

    Nov 1, 2014, 00:00

  • Microsimulation Model For The Assessment Of Personalized Cancer Care- The Mapcca Model Framework

    Nov 1, 2014, 00:00

  • Predicting the Impact of Adverse Events and Treatment Duration on Medical Resource Utilisation Related Costs in Hepatitis C Genotype 1 Treatment-Naïve Patients Receiving Antiviral Therapy

    Nov 1, 2014, 00:00

  • Hipos-ER (Hypoglycemia in Portugal Observational Study – Emergency Room)- Clinical Outcomes in the Emergency Room

    Nov 1, 2014, 00:00

  • Costs Per Successfully Treated Patient with Sofosbuvir in GT1 HCV

    Nov 1, 2014, 00:00

  • Impact of Health Policy Changes on the Growth Locally Manufactured and Imported Pharmaceutical Markets In Turkey

    Nov 1, 2014, 00:00

  • Cost Comparison Among First Line Monoclonal Antibodies-Based Oncology Treatment Protocols

    Nov 1, 2014, 00:00

  • Measuring Extent of Access For Nice Health Technology Assessment Decisions- Trends From 2008 to 2013

    Nov 1, 2014, 00:00

  • The Efficacy of Oximes in Acute Human Organophosphorus Poisoning; An Updated Meta-Analysis

    Nov 1, 2014, 00:00

  • A Cost Effectivness Analysis of Everolimus Compared with Axitinib in the Treatment of Metastatic Renal Cell Carcinoma in the United Kingdom

    Nov 1, 2014, 00:00

  • Efficacy Of Novel Dmards In Early Active Rheumatoid Arthritis- An Indirect Comparison

    Nov 1, 2014, 00:00

  • The Impact of Discrimination, Victimization and Social Standing on Health-Related Quality of Life

    Nov 1, 2014, 00:00

  • Prospective Study on Cost-Effectiveness of Nurse Interviw Introducing Retesting With in Vitro Diagnostics (IVD) To Parents of Children With Suspected Food Allergy in Finland

    Nov 1, 2014, 00:00

  • Dose Titration, Persistence, and Adherence to Statin Therapy Among Patients with High-Risk Vascular Disease in Japan

    Nov 1, 2014, 00:00

  • The Pain Assessment for Lower Back Symptoms (Pal-S)- Refinement of A New Pro Instrument Through A Mixed Methods Approach

    Nov 1, 2014, 00:00

  • Modeling the Effect of Combining Alogliptin With Dual therapy in Type 2 Diabetes

    Nov 1, 2014, 00:00

  • Whatever Happened To Nice Value-Based Pricing? Welcome, Value-Based Assessment

    Nov 1, 2014, 00:00
  • «
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98 (current)
  • 99
  • 100
  • »